Two Small Molecule Inhibitors Promote Reprogramming of Guangxi Bama Mini-Pig Mesenchymal Stem Cells Into Naive-Like State Induced Pluripotent Stem Cells.
Feng ChenDeshun ShiLingxiu ZouXiaoling YangShuye QiaoRuimen ZhangSufang YangYan-Fei DengPublished in: Cellular reprogramming (2021)
Past researches have shown that pluripotency maintenance of naive and primed-state pluripotent stem cells (PSCs) depends on different signaling pathways, and naive-state PSCs possess the ability to produce chimeras when they are introduced into a blastocyst. Considering porcine is an attractive model for preclinical studies, many researches about pig induced pluripotent stem cells (piPSCs) have been reported. Some cytokines and small molecule compounds could transform primed piPSCs into naive state. However, there are no suitable culture conditions for generation of naive-state piPSCs with high efficiency; other small molecule compounds need further exploration. In this study, we investigated whether p38 MAPK and JNK signal pathway inhibitor SB203580 and SP600125 could be of benefit for acquiring naive-state piPSCs. By comparing reprogramming efficiencies under conditions of different donor cells and culture environment, we found that porcine bone marrow mesenchymal stem cells (PBMSCs) have higher efficiency on piPSC induction, and the culture condition of CHIR99021+PD0325901(2i)+Lif+bFGF is more suitable for subculturing of piPSCs. Our results also indicate that SB203580 and SP600125 could promote reprogramming of PBMSCs into naive-like state piPSCs. These results provide guidance for choosing donor cells, culture conditions, and research of different state iPSCs during the process of reprogramming pig somatic cells.
Keyphrases
- small molecule
- induced apoptosis
- hiv infected
- induced pluripotent stem cells
- mesenchymal stem cells
- cell cycle arrest
- high efficiency
- gene expression
- endoplasmic reticulum stress
- stem cells
- oxidative stress
- protein protein
- antiretroviral therapy
- genome wide
- high resolution
- epithelial mesenchymal transition
- umbilical cord
- cell therapy
- pluripotent stem cells
- embryonic stem cells